116 related articles for article (PubMed ID: 19330649)
1. Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma.
Yang M; Shen JK; Huang J; Du HP; Ma QL; Jin J
Leuk Lymphoma; 2009 May; 50(5):802-8. PubMed ID: 19330649
[TBL] [Abstract][Full Text] [Related]
2. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
Yang M; Huang J; Pan HZ; Jin J
Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
[TBL] [Abstract][Full Text] [Related]
3. Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs.
Huang X; Yang M; Jin J
Leuk Lymphoma; 2012 Jun; 53(6):1188-95. PubMed ID: 22260163
[TBL] [Abstract][Full Text] [Related]
4. Triptolide blocks the STAT3 signaling pathway through induction of protein tyrosine phosphatase SHP-1 in multiple myeloma cells.
Kim JH; Park B
Int J Mol Med; 2017 Nov; 40(5):1566-1572. PubMed ID: 28901387
[TBL] [Abstract][Full Text] [Related]
5. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
Nakazato T; Sagawa M; Kizaki M
Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
[TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells.
Yinjun L; Jie J; Yungui W
Leuk Res; 2005 Jan; 29(1):99-105. PubMed ID: 15541481
[TBL] [Abstract][Full Text] [Related]
7. Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells.
Zhao F; Chen Y; Zeng LL; Li R; Zeng R; Wen L; Liu Y; Zhang C
Acta Pharmacol Sin; 2010 Jun; 31(6):733-40. PubMed ID: 20523343
[TBL] [Abstract][Full Text] [Related]
8. Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B.
Wen L; Chen Y; Zeng LL; Zhao F; Li R; Liu Y; Zhang C
Acta Pharmacol Sin; 2012 Jan; 33(1):109-19. PubMed ID: 22120968
[TBL] [Abstract][Full Text] [Related]
9. Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44.
Yi JM; Huan XJ; Song SS; Zhou H; Wang YQ; Miao ZH
Mol Cancer Ther; 2016 Jul; 15(7):1495-503. PubMed ID: 27197304
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
11. Triptolide-induced apoptosis by inactivating nuclear factor-kappa B apoptotic pathway in multiple myeloma in vitro.
Zeng R; Zeng L; Chen Y; Zhao F; Li R; Wen L; Zhang C
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):446. PubMed ID: 21823003
[TBL] [Abstract][Full Text] [Related]
12. [Effects of triptolide on bortezomib-induced apoptosis in multiple myeloma cells].
Yang Y; Dong HJ; Gao GX; Wang YW; Gu HT; Chen XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):335-8. PubMed ID: 22541093
[TBL] [Abstract][Full Text] [Related]
13. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
[TBL] [Abstract][Full Text] [Related]
15. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone reverses glucocorticoid receptor RNA depression in multi-drug resistant (MDR) myeloma cell lines.
Danel-Moore L; Brönnegard M; Gustafsson JA
Med Oncol Tumor Pharmacother; 1992; 9(4):199-204. PubMed ID: 1342065
[TBL] [Abstract][Full Text] [Related]
17. Overcoming glucocorticoid resistance: a new pathway from an ancient Chinese medicine?
Krett N; Ma S
Leuk Lymphoma; 2009 May; 50(5):689-90. PubMed ID: 19330651
[No Abstract] [Full Text] [Related]
18. [Effects of triptolide on the apoptosis and H3K4 protein methylation in multiple myeloma cells].
Xu CB; Liao B; Shen JZ; Fu HY; Lin T
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):450-455. PubMed ID: 29926592
[TBL] [Abstract][Full Text] [Related]
19. [Effect of triptolide on the proliferation and apoptosis of human epidermal squamous cell carcinoma cell line A431 in vitro].
Chen M; Tan S; Zhang G; Yi M; Jian D; Xie H; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 34(7):638-41. PubMed ID: 19648677
[TBL] [Abstract][Full Text] [Related]
20. MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status.
Li W; Liu Y; Li XX; Yu Y; Wu JJ; Wang Q; Huo H; Wang LM; Yang L
Planta Med; 2011 Jan; 77(1):27-31. PubMed ID: 20607649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
